Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.

SZSE:301096 Stock Report

Market Cap: CN¥7.6b

Hangzhou Bio-Sincerity Pharma-TechLtd Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Jinfang Lou

Chief executive officer

CN¥1.9m

Total compensation

CEO salary percentagen/a
CEO tenure8.3yrs
CEO ownership12.4%
Management average tenureno data
Board average tenure5.2yrs

Recent management updates

Recent updates

Should You Be Adding Hangzhou Bio-Sincerity Pharma-TechLtd (SZSE:301096) To Your Watchlist Today?

Mar 14
Should You Be Adding Hangzhou Bio-Sincerity Pharma-TechLtd (SZSE:301096) To Your Watchlist Today?

CEO

Jinfang Lou (55 yo)

8.3yrs

Tenure

CN¥1,948,000

Compensation

Ms. Lou Jinfang is Chairwoman of the Board of Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. from December 15, 2015.


Board Members

NamePositionTenureCompensationOwnership
Jinfang Lou
Chairwoman of the Board & GM8.3yrsCN¥1.95m12.41%
CN¥ 945.4m
Chunneng Shao
Deputy Chairman of the Board5.3yrsCN¥1.60m18.61%
CN¥ 1.4b
Hui Lin Li
Independent Director4.8yrsCN¥73.70kno data
Hui Ye
Supervisor5.1yrsno datano data

5.2yrs

Average Tenure

55yo

Average Age

Experienced Board: 301096's board of directors are considered experienced (5.2 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.